Transparency
At Gilead, we believe in transparency. Transparency of business practices that involve financial payments, or providing other forms of value, to health care professionals is essential for building trust with all of our stakeholders. As part of our on-going commitment to transparency, Gilead collects Transparency Data including information on who we make payments to, or provide other forms of value to (e.g. hospitality) and report as applicable to local laws and requirements.
For any questions, please contact us at: [email protected].
Transparency Reporting - Patient Organizations
See below for details of support provided by Gilead Sciences in the Nordics. The information is correct at the time of writing, February 2024. The information is subject to change and periodic updates.
See below for details of support provided by Gilead Sciences in Denmark. The information is correct at the time of writing February 2024. The information is subject to change and periodic updates.
Collaborations with Patient Organizations registered in Denmark 2024
Sponsoring and collaborations with NGOs in Denmark 2024
Sponsoring and Collaborations with NGOs in Denmark 2023
Gilead Sciences EFPIA Patient Organizations Support 2022 Denmark
Gilead Sciences EFPIA Patient Organizations Support 2021 Denmark
Sponsoring and Collaborations with NGOs in Finland 2024
Sponsorship and Collaborations with NGOs in Finland 2023
Gilead Sciences has not provided support to any patient organization in Finland in 2022 or 2021. The information is correct at the time of writing February 2024. The information is subject to change and periodic updates.
Gilead has not provided support to any patient organization in Iceland in 2023, 2022 or 2021. The information is correct at the time of writing February 2024. The information is subject to change and periodic updates.
See below for details of support provided by Gilead Sciences in Norway, via unrestricted educational grants. The information is correct at the time of writing February 2024. The information is subject to change and periodic updates.
Gilead Sciences did not provide support to any patient organizations or healthcare organizations in Norway in 2021, 2022 or 2023.
See below for details of support provided by Gilead Sciences in Sweden. The information is correct at the time of writing, February 2024. The information is subject to change and periodic updates.
Gilead Sciences did not provide support to any patient organizations or healthcare organizations in Sweden 2023.
Gilead Sciences EFPIA Patient Organizations Support 2022 Sweden
Gilead Sciences EFPIA Patient Organizations Support 2021 Sweden
Transparency Reporting - Healthcare Professionals / Healthcare Organizations
Gilead Sciences Finland EFPIA Report 2022 (in English)
Gilead Sciences Finland EFPIA Report 2022 (in Finnish)
Gilead Sciences Finland EFPIA Methodological Note 2022 (in English)
Gilead Sciences Finland EFPIA Methodological Note 2022 (in Finnish)
Gilead Sciences Finland EFPIA Report 2021 (in English)
Gilead Sciences Finland EFPIA Report 2021 (in Finnish)
Gilead Sciences Finland EFPIA Methodological Note 2021 (in English)
Gilead Sciences Finland EFPIA Methodological Note 2021 (in Finnish)
Gilead Sciences Norway EFPIA Report 2022 (in English)
Gilead Sciences Norway EFPIA Report 2022 (in Norwegian)
Gilead Sciences Norway EFPIA Methodological Note 2022 (in English
Gilead Sciences Norway EFPIA Methodological Note 2022 (in Norwegian)
Gilead Sciences Norway EFPIA Report 2021 (in English)
Gilead Sciences Norway EFPIA Report 2021 (in Norwegian)
Gilead Sciences Norway EFPIA Methodological Note 2021 (in English
Gilead Sciences Norway EFPIA Methodological Note 2021 (in Norwegian)
Gilead Sciences Sweden EFPIA Methodological Note 2022 (in English)
Gilead Sciences Sweden EFPIA Methodological Note 2022 (in Swedish)
Gilead Sciences Sweden EFPIA Report 2022 (in English)
Gilead Sciences Sweden EFPIA Report 2022 (in Swedish)
Gilead Sciences Sweden EFPIA Methodological Note 2021 (in English)
Gilead Sciences Sweden EFPIA Methodological Note 2021 (in Swedish)